Preclinical

Revenues from Translational Oncology Solutions, "TOS", previously referred to as Preclinical eValuation services, were $3.5 million for 2011 as the compared to $1.7 million in the prior year, an increase of $1.8 million, or 108%.

unknown title 2011

Title: Preclinical efficacy studies of influenza A haemagglutinin precursor cleavage loop peptides as a potential vaccine

Predicting ADHD Risk From Birth Ann Lukits 2011

Preclinical studies usually means testing in lab animals, not humans.

Isis and Genzyme Must Prove 2008

Preclinical studies indicated that Tamiflu, when combined with Ampligen, achieved full inhibition of the H5N1 virus using just 1% to 2% of the Tamiflu needed to combat the virus on its own.

Hemispherx Biopharma's Ampligen Boosts Tamiflu Potency 2006

Preclinical data revealed that the company's unorthodox treatment, utilizing zinc finger proteins, can modify immune system cells which then render them permanently resistant to HIV.

Eye On Stocks For Thursday, Sept. 28 Eye On Stocks For Thursday, Sept. 28, 2006 2006

Preclinical studies have shown that OXi4503 has single-agent activity against a range of xenograft tumor models; and synergistic or additive effects when incorporated in various combination regimens with chemotherapy, molecularly-targeted therapies including tumor-angiogenesis inhibitors, and radiation therapy.

unknown title 2011

Alexandra Schiviz, manager, department of pharmacology, toxicology and preclinical development, BioTherapeutics, Baxter Innovations GmbH, Vienna, Austria, presenting "Preclinical efficacy testing of Baxter's recombinant ADAMTS 13 in a mouse model of TTP."

unknown title 2011

Preclinical research has demonstrated that Kappa blockade has antidepressant effects in behavioral models of depression.

Alkermes Provides Update on Advancing Product Portfolio and Outlines Business Goals for 2011 - Yahoo! Finance 2011

Hartikka, Ph.D., Vical's Associate Director of Vaccinology, "Preclinical Evaluation of the Immunogenicity of Plasmid DNA-based Prophylactic Vaccines for Human Cytomegalovirus," detailed the preclinical results supporting clinical development of the company's CyMVectinTM prophylactic CMV vaccine.

unknown title 2011

Around co-founders Roy and Jus, a great team coalesced shortly after founding: Nagesh Mahanthappa on BD, Wes Westlin on Preclinical, and Russ Petter on Chemistry.

Forbes.com: News Bruce Booth 2012